Docusign Inc. $DOCU Shares Sold by Robeco Institutional Asset Management B.V.

Posted by Brenda Bartman on Oct 22nd, 2026

Robeco Institutional Asset Management B.V. lowered its stake in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) by 21.6% during the third quarter, Holdings Channel reports. The fund owned 1,169,848 shares of the company’s stock after selling 321,705 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Docusign were worth $78,555,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its stake in shares of Docusign by 23.3% during the first quarter. Bank of America Corp DE now owns 1,193,163 shares of the company’s stock valued at $56,568,000 after purchasing an additional 225,801 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of Docusign by 247.5% in the second quarter. Assenagon Asset Management S.A. now owns 349,038 shares of the company’s stock valued at $15,504,000 after purchasing an additional 248,597 shares in the last quarter. Jefferies Financial Group Inc. acquired a new stake in shares of Docusign in the second quarter valued at approximately $691,000. OP Asset Management Ltd acquired a new stake in shares of Docusign in the first quarter valued at approximately $3,931,000. Finally, Two Sigma Securities LLC bought a new position in Docusign in the 2nd quarter worth approximately $1,376,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Docusign Trading Up 1.5%

NASDAQ DOCU opened at $81.48 on Thursday. The company has a market capitalization of $15.23 billion, a PE ratio of 49.68, a P/E/G ratio of 2.97 and a beta of 0.86. The stock has a 50-day simple moving average of $67.89 and a 200 day simple moving average of $55.43. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $81.62.

Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The business had revenue of $875.75 million for the quarter, compared to the consensus estimate of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. Docusign’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period last year, the company posted $0.30 EPS. As a group, sell-side analysts predict that Docusign Inc. will post 2.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

DOCU has been the topic of several research reports. Wall Street Zen downgraded Docusign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 2nd. Weiss Ratings upgraded Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Bank of America lifted their target price on Docusign from $58.00 to $64.00 and gave the company an “underperform” rating in a research note on Friday, September 4th. Piper Sandler lifted their target price on Docusign from $52.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Finally, Wells Fargo & Company boosted their target price on Docusign from $55.00 to $60.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. Three analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $67.62.

View Our Latest Report on Docusign

Insider Activity at Docusign

In related news, Director Mary Wilderotter sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $68.80, for a total value of $68,800.00. Following the completion of the transaction, the director directly owned 2,199 shares in the company, valued at approximately $151,291.20. The trade was a 31.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 14,676 shares of the business’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $69.41, for a total value of $1,018,661.16. Following the completion of the transaction, the insider owned 75,928 shares of the company’s stock, valued at $5,270,162.48. This represents a 16.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 165,868 shares of company stock valued at $11,121,890 over the last 90 days. Insiders own 0.59% of the company’s stock.

Docusign Profile

(Free Report)

DocuSign, Inc is a software company that provides digital agreement and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping customers replace paper-based contracting processes with digital workflows.

The company’s offerings include eSignature, contract lifecycle management, identity verification, notarization and agreement analytics tools. These products are designed to support agreement creation, negotiation, execution and post-signature management across functions such as sales, human resources, procurement, legal and finance.

Founded in 2003, DocuSign serves businesses, government organizations and individual users in markets around the world.